Rejuvenation Technologies Inc.

[Available On-Demand]
Rejuvenation Technologies is a venture-backed biotech startup company out of Stanford University developing anti-aging therapeutics. Rejuvenation’s founders invented their lead compound, TERT mRNA. TERT mRNA extends telomeres in days sufficiently to reverse years of telomere shortening during aging. Rejuvenation hit their 2019 seed round preclinical milestones in 2020 showing that TERT mRNA-based telomere extension reduces fibrosis and extends survival in mice. Now with their upcoming Series A round Rejuvenation aims to achieve IND approval for their first formulation in 2022 and expand their pipeline to target other indications and aging mechanisms.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
TERT mRNA
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
CEO
Rejuvenation Technologies Inc.